ETERNAL and four other Horizon Europe research projects. have joined forces to form a Green Pharma Horizon Projects Cluster and capitalize on synergistic development. The aim of this cluster of R&D projects is to increase the sustainability of pharmaceutical products and exploit research synergies to boost the impact of innovations. Three working groups have been created: active pharmaceutical ingredient synthesis, pharmaceutical life cycle assessment and communication of key messages.
20 May 2024
The ETERNAL project held a successful kick-off meeting in Valencia, Spain on 27th and 28th September. This new four-year EC Horizon Europe Research and Innovation Action will contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycle approaches covering design, manufacture, usage, and disposal, assessing the environmental risks of not only active pharmaceutical ingredients and residues or metabolites, but other chemicals and by-products of the production process. In other words, safe and sustainable pharmaceutical lifecycles by design.
28 September 2022This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy. By clicking Accept, you consent to our use of cookies.